Physician profile
Jay D Pond
NPI 1780679886
$9,009.92
in general payments reported to CMS, 2019-2025
15 companies · $707 in 2025
The $707 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,908 · 2020: $582 · 2021: $1,840 · 2022: $2,444 · 2023: $124 · 2024: $403 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,234.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,969.65 | 2019-2025 | |
| Arthrex, INC. | $2,236.36 | 2022 | |
| Advanced Orthopaedic Solutions, INC. | $1,911.33 | 2019 | |
| Zimmer Biomet Holdings, INC. | $708.53 | 2019-2025 | Oxford, Identity, Saw Guide |
| Omnilife Science, INC | $220.35 | 2019-2021 | |
| Smith+Nephew, INC. | $173.32 | 2019-2022 | |
| Kyocera Medical Technologies, INC. | $166.78 | 2021-2024 | |
| Stryker Corporation | $141.95 | 2024 | Blueprint Patient Specific Instrumentation |
| Anika Therapeutics, INC. | $99.27 | 2021 | |
| Skeletal Dynamics INC | $95.15 | 2020 | |
| Bioventus LLC | $69.59 | 2019-2024 | Durolane |
| Depuy Synthes Sales INC. | $68.34 | 2020-2025 | Na |
| Ferring Pharmaceuticals INC. | $64.51 | 2023-2025 | Euflexxa |
| Ethicon US, LLC | $55.32 | 2025 | Vistaseal |
| Sanofi-Aventis U.S. LLC | $29.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Pond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.